-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Uff1C0cU5J53+yFTcGoCQJM27bc0BkhzadPdRdFzl+ySgUWG1Q8ioYpgo1uCPz0N qnkq+nSklEe8sncon4JinQ== 0001237899-11-000012.txt : 20110111 0001237899-11-000012.hdr.sgml : 20110111 20110111160852 ACCESSION NUMBER: 0001237899-11-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110107 FILED AS OF DATE: 20110111 DATE AS OF CHANGE: 20110111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTS WILLIAM CENTRAL INDEX KEY: 0001226687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 11522857 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2011-01-07 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226687 ROBERTS WILLIAM 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Regul Devel & Med Safety Common Stock 2011-01-07 4 M 0 10000 9.49 A 76956 D Common Stock 2011-01-07 4 F 0 2777 34.17 D 74179 D Common Stock 2011-01-07 4 F 0 2616 34.17 D 71563 D Common Stock 1200 I by trust for daught Common Stock 3906 I By 401(k) Plan Common Stock 16147 I by Spouse Common Stock 1200 I by trust for daught Non-Qualified Stock Option (right to buy) 9.49 2011-01-07 4 M 0 10000 D 2014-12-15 Common Stock 10000 8812 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**William G. Roberts 2011-01-11 -----END PRIVACY-ENHANCED MESSAGE-----